Pressure Biosciences Inc
(PBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 422 | 349 | 312 | 413 | 512 |
| Cost of Goods | 378 | 233 | 334 | 230 | 257 |
| Gross Profit | 44 | 116 | -21 | 184 | 255 |
| Operating Expenses | 2,350 | 1,834 | 3,804 | 1,706 | 1,593 |
| Operating Income | -1,929 | -1,485 | -3,491 | -1,293 | -1,082 |
| Interest Expense | 3,535 | 5,385 | 1,469 | 4,339 | 5,880 |
| Other Income | -1,653 | -1,205 | -4,943 | 2 | 39 |
| Pre-tax Income | -7,117 | -8,074 | -9,904 | -5,630 | -6,923 |
| Net Income Continuous | -7,117 | -8,074 | -9,904 | -5,630 | -6,923 |
| Net Income | $-7,117 | $-8,074 | $-9,904 | $-5,630 | $-6,923 |
| EPS Basic Total Ops | -0.15 | -0.22 | -0.19 | -0.29 | -0.57 |
| EPS Basic Continuous Ops | -0.14 | -0.20 | -0.21 | -0.26 | -0.36 |
| EPS Diluted Total Ops | -0.15 | -0.22 | -0.19 | -0.29 | -0.57 |
| EPS Diluted Continuous Ops | -0.14 | -0.20 | -0.21 | -0.26 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.22 | -0.30 | -0.29 | -0.57 |
| EBITDA(a) | $-1,129 | $163 | $-4,170 | $124 | $157 |